We are delighted to announce that we've reschduled the LivWiSE discussion on 'What's the future of Personalised Health?' to Thursday 3 May 2018 @ 5pm.
Personalised health is a new term being used to describe the future of healthcare, but what does this mean? Humans are all unique and the state of our health is influenced by many factors including genetics, lifestyle and environment. By examining and analysing our individual information, patterns can be identified to help determine our individual risk of developing disease, detect illness earlier and find the most effective interventions to help improve our health.
Our panel of experts will be discussing the medical move away from ‘one size fits all’ approach, the achievements and challenges of technological and scientific advances and the future of personalised health.
Dr Rachel Bearon - leads the mathematical biology research group and is responsible for User Engagement at the Liverpool Centre of Mathematics for Healthcare (LCMH). She has extensive experience of developing models bridging spatial and temporal scales to make biological predictions concerning the movement of cells within complex environments. Furthermore, she has significant expertise working directly with experimental biologists to develop novel frameworks for processing and integrating imaging data. Rachel applies and develops mathematics to study the spatial and temporal dynamics of a wide range of biological systems across multiple scales, ranging from bacterial chemotaxis from the swimming micro-organisms phytoplankton in turbulence to modelling cell-signalling pathways and intracellular protein dynamics.
Dr Andrea Jorgensen - qualified with an MSc (Distinction) in Medical Statistics at Lancaster University in 2004 (sponsored by AstraZeneca), and was awarded a PhD in Medical Statistics from the University of Liverpool in 2010. Currently a Senior Lecturer in Biostatistics at the University of Liverpool, specialising in statistical methods for pharmacogenetics and stratified medicine. Dr Jorgensen's main research interests include statistical methods for pharmcogenetic studies and stratified medicine, randomised controlled trials in stratified medicine, meta-analysis of pharmacogenetics studies, and methodological quality of pharmacogenetic studies.
Dr Rebecca Davnall - Lecturer in the Department of Philosophy at the University of Liverpool, with a focus on "Philosophy of the Future" the philosophical implications of foreseeable future technological innovations and examines the relevance of metaphysical and ethical considerations to future technological and scientific developments.
Dr Gemm Nixon - In 2013 Gemma was the Chemistry Team Leader on the AWOL II: Macrofilaricidial Drug Discovery Project at LSTM (funded by the Bill & Melinda Gates Foundation (BMGF)) and in May 2016 was awarded an MRC New Investigator Research Grant to investigate the 'Rational Design, Synthesis and Biological Evaluation of Benzimidazoles; Towards a Novel Therapy Selectively Targeting C. neoformans β-tubulin'. Research interests include several areas of medicinal chemistry drug discovery and target identification. With a strong emphasis on development of novel therapies used in the treatment of tuberculosis, malaria, Cryptococcus neoformans and filariasis.
To book your place visit Evenbrite: LivWiSE 'What's the Future of Personalised Health?'